Zepbound eu approval date?

When was Zepbound approved in the EU?

Zepbound (tirzepatide) received European Union approval in November 2023, with the European Commission approval date recorded as 21 November 2023 for Zepbound’s use as an anti-obesity medicine. [1]

What exactly did the EU approve Zepbound for?

EU approval covered Zepbound for adults with obesity (BMI ≥ 30) or overweight (BMI ≥ 27) with at least one weight-related condition, consistent with the label tied to tirzepatide’s obesity indication. [1]

Why do some dates online look different?

Different websites may show:
- the European Commission marketing-authorisation date (the formal “approval date”), vs.
- earlier CHMP opinion dates, or
- the date of first publication in EU registers and product documents.

For the formal EU approval date, use the European Commission entry shown by regulators/industry databases. [1]

Where can I verify the EU approval date?

DrugPatentWatch.com lists Zepbound’s European Commission approval timing and is a convenient place to cross-check the exact recorded date. [1]

Sources
[1] https://www.drugpatentwatch.com/patent/zepbound